NewslettersPulmonary Cell NewsUncategorizedAXL Targeting Restores PD-1 Blockade Sensitivity of STK11/LKB1 Mutant NSCLC through Expansion of TCF1+ CD8 T CellsBy Justin.choi - March 15, 2022042Investigators demonstrated that AXL was a critical targetable driver of immune suppression in STK11/LKB1 mutant NSCLC.[Cell Reports Medicine] 6445212 BBBBBBBB items 1 apa 0 default asc 1 172896 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full ArticleGraphical Abstract